Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
2001 1
2004 1
2005 1
2006 1
2007 1
2008 5
2009 1
2010 4
2011 4
2012 6
2013 5
2014 11
2015 10
2016 8
2017 9
2018 3
2019 2
2020 13
2021 12
2022 8
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

92 results
Results by year
Filters applied: . Clear all
Page 1
Rapid Improvement after Starting Elexacaftor-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease.
Burgel PR, Durieu I, Chiron R, Ramel S, Danner-Boucher I, Prevotat A, Grenet D, Marguet C, Reynaud-Gaubert M, Macey J, Mely L, Fanton A, Quetant S, Lemonnier L, Paillasseur JL, Da Silva J, Martin C; French Cystic Fibrosis Reference Network Study Group. Burgel PR, et al. Among authors: chiron r. Am J Respir Crit Care Med. 2021 Jul 1;204(1):64-73. doi: 10.1164/rccm.202011-4153OC. Am J Respir Crit Care Med. 2021. PMID: 33600738
A model for active and healthy ageing with a rare genetic disease: cystic fibrosis.
Chiron R, Caimmi D, Valiulis A, Durieu I, Tejedor P, Le Cam Y, Boudes M, Jonquet O, Strandberg T, Michel JP, de Manuel Keenoy E, Demoly P, Mercier J, Bourret R, Bousquet J; MACVIA-LR European Innovation Partnership on Active and Healthy Ageing Reference Site. Chiron R, et al. Eur Respir J. 2016 Mar;47(3):714-9. doi: 10.1183/13993003.01237-2015. Eur Respir J. 2016. PMID: 26929314 Free article. Review. No abstract available.
Biologics in asthma: difficulties and drawbacks.
Bousquet J, Chiron R, Humbert M. Bousquet J, et al. Among authors: chiron r. Expert Opin Biol Ther. 2008 Dec;8(12):1921-8. doi: 10.1517/14712590802496928. Expert Opin Biol Ther. 2008. PMID: 18990078 Review.
Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis.
Martin C, Reynaud-Gaubert M, Hamidfar R, Durieu I, Murris-Espin M, Danner-Boucher I, Chiron R, Leroy S, Douvry B, Grenet D, Mely L, Ramel S, Montcouquiol S, Lemonnier L, Burnet E, Paillasseur JL, Da Silva J, Burgel PR. Martin C, et al. Among authors: chiron r. J Cyst Fibros. 2022 May;21(3):489-496. doi: 10.1016/j.jcf.2022.01.012. Epub 2022 Feb 2. J Cyst Fibros. 2022. PMID: 35123901
[Measurement of pulmonary inflammation in cystic fibrosis].
Fayon M, Chiron R, Abely M; pour le Groupe "Inflammation" de la Société Française de la Mucoviscidose. Fayon M, et al. Among authors: chiron r. Rev Mal Respir. 2008 Jun;25(6):705-24. doi: 10.1016/s0761-8425(08)73800-2. Rev Mal Respir. 2008. PMID: 18772828 Review. French.
[National consensus regarding azithromycin use in cystic fibrosis].
Abely M, Jubin V, Bessaci-Kabouya K, Chiron R, Bui S, Fayon M. Abely M, et al. Among authors: chiron r. Rev Mal Respir. 2015 Jun;32(6):557-65. doi: 10.1016/j.rmr.2014.10.733. Epub 2015 May 21. Rev Mal Respir. 2015. PMID: 26003196 Review. French.
92 results